MASSDEVICE ON CALL — A new surgical robot designed to bring ease and precision to eye surgeries may hit the market, if inventor Thijs Meenink can defend his PhD thesis work on the machine.
Meenink, a student at Eindhoven University of Technology, plans to commercialize the novel robot after he obtains his doctorate.
The surgical system can filter out a surgeon’s hand tremors and always enters the eye at the same exact same location to avoid damaging delicate eye structures. The devices also includes an "instrument changer" so the robot can switch from scissors to forceps or other instruments in seconds and allows for highly precise movements by scaling down a surgeon’s movements.
There is no other surgical robot on the market now optimized for ophthalmological procedures, HealthCanal.com reported.
Steve Jobs’ new biography highlights the decisions that may have hastened his death
Harvard Medical School researcher Ramzi Amri won validation for his insights into how former Apple CEO Steve Jobs’ stubbornness against accepted medical treatments for his pancreatic cancer may have hastened his death as the tech guru’s recently released biography outlines the years Jobs waited before properly treatment. But hindsight doesn’t provide certainty, the New York Times reported.
$6.8 billion in unnecessary medical bills every year
Expensive and often inappropriate tests are costing the U.S. $6.8 billion every year, Kaiser Health News reported.
Ireland lures businesses with low worker wages
Barry O’Leary, CEO Of Ireland’s inward investment government agency IDA Ireland, said high unemployment rates and hard economic times are an incentive for businesses looking to lower costs with lower worker wages and lower corporate tax rates, the Star Tribune reported.
Philips enters the North American mammography market for Breast Cancer Awareness Month
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.